• AZD2461: Novel PARP Inhibitor Workflows for Breast Cancer...

  2026-01-20

  AZD2461 is a next-generation poly (ADP-ribose) polymerase inhibitor engineered to address DNA repair pathway vulnerabilities in breast cancer models—especially those with BRCA1 mutations or drug resistance. This guide details applied protocols, advanced use-cases, and troubleshooting strategies to maximize assay reproducibility and scientific impact using APExBIO’s validated AZD2461 compound.

• Clodronate Liposomes: Precision Macrophage Depletion Reag...

  2026-01-20

  Clodronate Liposomes enable targeted in vivo macrophage depletion, supporting advanced research in immune cell modulation and cancer immunotherapy. As a macrophage depletion reagent, this product offers robust, reproducible results in transgenic mouse and inflammation models. APExBIO’s K2721 kit is benchmarked for selectivity, tissue specificity, and compatibility with diverse administration routes.

407 records 28/28 page Previous First page 上5页 262728